Håkan Olsson (Former)
1 – 50 of 534
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions
(
- Contribution to journal › Article
- 2023
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
(
- Contribution to journal › Article
- 2022
-
Mark
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
(
- Contribution to journal › Article
-
Mark
Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer
(
- Contribution to journal › Article
-
Mark
Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study
(
- Contribution to journal › Article
-
Mark
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
(
- Contribution to journal › Article
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
(
- Contribution to journal › Article
-
Mark
Rare germline copy number variants (CNVs) and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Copy number variants are ovarian cancer risk alleles at known and novel risk loci
(
- Contribution to journal › Article
- 2021
-
Mark
Multiple primary melanoma incidence trends over five decades, a nation-wide population-based study
(
- Contribution to journal › Article
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
(
- Contribution to journal › Article
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
-
Mark
Low sun exposure habits is associated with a dose-dependent increased risk of hypertension : a report from the large MISS cohort
(
- Contribution to journal › Article
-
Mark
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
(
- Contribution to journal › Article
-
Mark
Genetic testing in women with early-onset breast cancer : a Traceback pilot study
(
- Contribution to journal › Article
-
Mark
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
(
- Contribution to journal › Article
-
Mark
Genetic insights into biological mechanisms governing human ovarian ageing
(
- Contribution to journal › Article
-
Mark
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
(
- Contribution to journal › Article
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
-
Mark
CYP3A7*1C allele : linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
(
- Contribution to journal › Article
-
Mark
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study
(
- Contribution to journal › Article
-
Mark
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(1). p.217-228(
- Contribution to journal › Article
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642(
- Contribution to journal › Article
-
Mark
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
(
- Contribution to journal › Article
-
Mark
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
(
- Contribution to journal › Article
-
Mark
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article
-
Mark
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
(
- Contribution to journal › Article
-
Mark
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
(
- Contribution to journal › Letter
-
Mark
Increased cancer risk in families with pediatric cancer is associated with gender, age, diagnosis, and degree of relation to the child
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(11). p.2171-2179(
- Contribution to journal › Article
-
Mark
The Menstrual Cycle and Risk of Breast Cancer : A Review
(
- Contribution to journal › Scientific review
-
Mark
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
(
- Contribution to journal › Article
-
Mark
Women with fair phenotypes seem to confer a survival advantage in a low UV milieu. A nested matched case control study
(
- Contribution to journal › Article
-
Mark
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
(
- Contribution to journal › Article
-
Mark
Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer : A Population-Based Study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
(
- Contribution to journal › Article
-
Mark
Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight
(
- Contribution to journal › Article
-
Mark
Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers : Results from the BRCA1 and BRCA2 cohort consortium
(
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine use associated with improved melanoma survival
(
- Contribution to journal › Letter